Market Research Logo

Injectable Drug Delivery - Global Market Outlook (2017-2026)

Injectable Drug Delivery - Global Market Outlook (2017-2026)

According to Stratistics MRC, the Global Injectable Drug Delivery market is expected to grow from $404.14 billion in 2017 to reach $1199.89 billion by 2026 with a CAGR of 12.8%. Increasing prevalence of chronic diseases, expansion in the biologics market and technological advances in the form of nanotechnologies are some of the factors propelling the market growth. However, growing injuries and the infections caused by needles is hampering the market growth.

Drug delivery is the method of administering a pharmaceutical compound into the body through different routes to achieve a therapeutic effect. Oral, injection-based, transdermal, and carrier-based are some of the types of drug delivery devices. Injectable drug delivery facilitates the rapid transport of a drug into the body by passing first-pass metabolism. It also helps in administering drugs in unconscious and comatose patients. It is used in conditions such as hormonal imbalance, cystic fibrosis, autoimmune diseases, pain, Wilson’s disease, hemophilia, hepatitis C and ribose-5-phosphate isomerase deficiency.

Based on formulation packaging, Ampules segment has a significant growth in the market owing to its good barrier properties as compared to other types of packaging. In addition they offer better protection at a lesser cost, ease of transportation and low costs of manufacturing are the factors driving the market in this segment.

By Geography, North America was estimated to be the largest share for the market during the forecast period. The growth is attributed to the rising dominance of chronic diseases and the number of companies that are focused on collaboration and partnerships to ensure the availability of high-value products.

Some of the key players in the Injectable Drug Delivery market include Baxter International, Inc., ELI Lilly and Company, Terumo Corporation, Becton, Dickinson and Company, Pfizer, Inc., Gerresheimer AG, Teva Pharmaceutical Industries Ltd., Schott AG, Sandoz, Antares Pharma, Inc., Zogenix, Inc., Scandinavian Health Limited, Terumo Medical Corp., Ypsomed Holding AG, Unilife Corporation, Vetter Pharma-Fertigung GmbH & Co. KG and Nova Nordisk A/S.

Types Covered:
• Formulations
• Devices

Formulation Packagings Covered:
• Cartridges
• Ampules
• Bottles
• Vials

Usage Patterns Covered:
• Immunization
• Curative Care
• Other Usage Patterns

Facility of Uses Covered:
• Home Care Settings
• Hospitals and Clinics
• Other Facilities of Use

Site of Administrations Covered:
• Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
• Skin (Intradermal and Subcutaneous)
• Central Nervous System (Intracerebral and Intrathecal)
• Organs (Intravitreal and Intra-Articular)

Applications Covered:
• Hormonal Disorders
• Autoimmune Diseases
• Cancer
• Orphan Diseases
• Cardiovascular diseases
• Neurology Addiction
• Respiratory Diseases
• Regenerative Medicine
• Oncology
• Other Therapeutic Applications

Distribution Channels Covered:
• Retail Pharmacy Stores
• Hospitals
• E-Commerce

End Users Covered:
• Ambulatory Care
• Home Based
• Clinics/Physician Offices
• Other End Users

Regions Covered:
• North America
US
Canada
Mexico
• Europe
Germany
UK
Italy
France
Spain
Rest of Europe
• Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
• South America
Argentina
Brazil
Chile
Rest of South America
• Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends.
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements.


1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Injectable Drug Delivery Market, By Type
5.1 Introduction
5.2 Formulations
5.2.1 Novel Drug Delivery Formulations
5.2.1.1 Microparticles
5.2.1.1.1 Microcapsules
5.2.1.1.2 Microspheres
5.2.1.2 Colloidal Dispersions
5.2.1.2.1 Polymeric/Mixed Micelles
5.2.1.2.2 Niosomes
5.2.1.2.3 Liposomes
5.2.1.2.4 Nanoparticles
5.2.1.2.4.1 Nanoemulsions
5.2.1.2.4.2 Solid-Lipid Nanoparticles
5.2.1.2.4.3 Nanosuspensions
5.2.2 Conventional Drug Delivery Formulations
5.2.2.1 Reconstituted/Lyophilized Formulations
5.2.2.2 Emulsions
5.2.2.3 Solutions
5.2.2.4 Suspensions
5.2.3 Long-Acting Injection Formulations
5.3 Devices
5.3.1 Conventional Injection Devices
5.3.1.1 Material
5.3.1.1.1 Plastic
5.3.1.1.2 Glass
5.3.1.2 Usability
5.3.1.2.1 Disposable Injection Devices
5.3.1.2.2 Reusable Injection Devices
5.3.1.3 Product
5.3.1.3.1 Prefilled Syringes
5.3.1.3.2 Fillable Syringes
5.3.2 Self-Injection Devices
5.3.2.1 Needle-Free Injectors
5.3.2.1.1 Technology
5.3.2.1.1.1 Spring-Based Needle-Free Injectors
5.3.2.1.1.2 Vibration-Based Needle-Free Injectors
5.3.2.1.1.3 Jet-Based Needle-Free Injectors
5.3.2.1.1.4 Laser-Powered Needle-Free Injectors
5.3.2.1.2 Product
5.3.2.1.2.1 Prefilled Needle-Free Injectors
5.3.2.1.2.2 Fillable Needle-Free Injectors
5.3.2.1.3 Usability
5.3.2.1.3.1 Disposable Needle-Free Injectors
5.3.2.1.3.2 Reusable Needle-Free Injectors
5.3.2.2 Autoinjectors
5.3.2.2.1 Design
5.3.2.2.1.1 Customized Autoinjectors
5.3.2.2.1.2 Standardized Autoinjectors
5.3.2.2.2 Technology
5.3.2.2.2.1 Manual Autoinjectors
5.3.2.2.2.2 Automated Autoinjectors
5.3.2.2.3 Product
5.3.2.2.3.1 Prefilled Autoinjectors
5.3.2.2.3.2 Fillable Autoinjectors
5.3.2.2.4 Usability
5.3.2.2.4.1 Disposable Autoinjectors
5.3.2.2.4.2 Reusable Autoinjectors
5.3.2.3 Pen Injectors
5.3.2.3.1 Design
5.3.2.3.1.1 Customized Pen Injectors
5.3.2.3.1.2 Standard Pen Injectors
5.3.2.3.2 Product
5.3.2.3.2.1 Dual-Chambered Pen Injectors
5.3.2.3.2.2 Single-Chambered Pen Injectors
5.3.2.3.3 Usability
5.3.2.3.3.1 Disposable Pen Injectors
5.3.2.3.3.2 Reusable Pen Injectors
5.3.2.4 Wearable Injectors
5.3.3 Integrated safety syringes
5.3.4 Patch injectors
5.3.5 Safety Syringes
5.3.6 Subcutaneous infusion devices
5.3.7 Other Devices
6 Global Injectable Drug Delivery Market, By Formulation Packaging
6.1 Introduction
6.2 Cartridges
6.3 Ampules
6.4 Bottles
6.5 Vials
7 Global Injectable Drug Delivery Market, By Usage Pattern
7.1 Introduction
7.2 Immunization
7.3 Curative Care
7.4 Other Usage Patterns
8 Global Injectable Drug Delivery Market, By Facility of Use
8.1 Introduction
8.2 Home Care Settings
8.3 Hospitals and Clinics
8.4 Other Facilities of Use
9 Global Injectable Drug Delivery Market, By Site of Administration
9.1 Introduction
9.2 Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)
9.3 Skin (Intradermal and Subcutaneous)
9.4 Central Nervous System (Intracerebral and Intrathecal)
9.5 Organs (Intravitreal and Intra-Articular)
10 Global Injectable Drug Delivery Market, By Application
10.1 Introduction
10.2 Hormonal Disorders
10.2.1 Anemia
10.2.2 Antithrombotic/Thrombolytic Therapy
10.2.3 Growth Hormone Deficiency (GHD)
10.2.4 Diabetes
10.2.5 Osteoporosis
10.2.6 Reproductive Health Disease
10.3 Autoimmune Diseases
10.3.1 Multiple Sclerosis (MS)
10.3.2 Psoriasis
10.3.3 Rheumatoid Arthritis
10.3.4 Crohn’s Disease
10.3.5 Other Autoimmune Diseases
10.4 Cancer
10.5 Orphan Diseases
10.6 Cardiovascular diseases
10.7 Neurology Addiction
10.8 Respiratory Diseases
10.9 Regenerative Medicine
10.10 Oncology
10.11 Other Therapeutic Applications
10.11.1 Aesthetic Treatment
10.11.2 Pain Management
10.11.3 Hemophilia
10.11.4 Hepatitis C
10.11.5 Allergies
11 Global Injectable Drug Delivery Market, By Distribution Channel
11.1 Introduction
11.2 Retail Pharmacy Stores
11.3 Hospitals
11.4 E-Commerce
12 Global Injectable Drug Delivery Market, By End User
12.1 Introduction
12.2 Ambulatory Care
12.3 Home Based
12.4 Clinics/Physician Offices
12.5 Other End Users
13 Global Injectable Drug Delivery Market, By Geography
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 Germany
13.3.2 UK
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia Pacific
13.4.1 Japan
13.4.2 China
13.4.3 India
13.4.4 Australia
13.4.5 New Zealand
13.4.6 South Korea
13.4.7 Rest of Asia Pacific
13.5 South America
13.5.1 Argentina
13.5.2 Brazil
13.5.3 Chile
13.5.4 Rest of South America
13.6 Middle East & Africa
13.6.1 Saudi Arabia
13.6.2 UAE
13.6.3 Qatar
13.6.4 South Africa
13.6.5 Rest of Middle East & Africa
14 Key Developments
14.1 Agreements, Partnerships, Collaborations and Joint Ventures
14.2 Acquisitions & Mergers
14.3 New Product Launch
14.4 Expansions
14.5 Other Key Strategies
15 Company Profiling
15.1 Baxter International, Inc.
15.2 ELI Lilly and Company
15.3 Terumo Corporation
15.4 Becton, Dickinson and Company
15.5 Pfizer, Inc.
15.6 Gerresheimer AG
15.7 Teva Pharmaceutical Industries Ltd.
15.8 Schott AG
15.9 Sandoz
15.1 Antares Pharma, Inc.,
15.11 Zogenix, Inc.
15.12 Scandinavian Health Limited
15.13 Terumo Medical Corp.,
15.14 Ypsomed Holding AG
15.15 Unilife Corporation,
15.16 Vetter Pharma-Fertigung GmbH & Co. KG.
15.17 Nova Nordisk A/S
List of Tables
Table 1 Global Injectable Drug Delivery Market Outlook, By Region (2016-2026) ($MN)
Table 2 Global Injectable Drug Delivery Market Outlook, By Type (2016-2026) ($MN)
Table 3 Global Injectable Drug Delivery Market Outlook, By Formulations(2016-2026) ($MN)
Table 4 Global Injectable Drug Delivery Market Outlook, By Novel Drug Delivery Formulations (2016-2026) ($MN)
Table 5 Global Injectable Drug Delivery Market Outlook, By Conventional Drug Delivery Formulations (2016-2026) ($MN)
Table 6 Global Injectable Drug Delivery Market Outlook, By Long-Acting Injection Formulations (2016-2026) ($MN)
Table 7 Global Injectable Drug Delivery Market Outlook, By Devices(2016-2026) ($MN)
Table 8 Global Injectable Drug Delivery Market Outlook, By Conventional Injection Devices (2016-2026) ($MN)
Table 9 Global Injectable Drug Delivery Market Outlook, By Self-Injection Devices (2016-2026) ($MN)
Table 10 Global Injectable Drug Delivery Market Outlook, By Integrated safety syringes (2016-2026) ($MN)
Table 11 Global Injectable Drug Delivery Market Outlook, By Patch injectors (2016-2026) ($MN)
Table 12 Global Injectable Drug Delivery Market Outlook, By Safety Syringes (2016-2026) ($MN)
Table 13 Global Injectable Drug Delivery Market Outlook, By Subcutaneous infusion devices (2016-2026) ($MN)
Table 14 Global Injectable Drug Delivery Market Outlook, By Other Devices (2016-2026) ($MN)
Table 15 Global Injectable Drug Delivery Market Outlook, By Formulation Packaging (2016-2026) ($MN)
Table 16 Global Injectable Drug Delivery Market Outlook, By Cartridges(2016-2026) ($MN)
Table 17 Global Injectable Drug Delivery Market Outlook, By Ampules (2016-2026) ($MN)
Table 18 Global Injectable Drug Delivery Market Outlook, By Bottles (2016-2026) ($MN)
Table 19 Global Injectable Drug Delivery Market Outlook, By Vials (2016-2026) ($MN)
Table 20 Global Injectable Drug Delivery Market Outlook, By Usage Pattern (2016-2026) ($MN)
Table 21 Global Injectable Drug Delivery Market Outlook, By Immunization(2016-2026) ($MN)
Table 22 Global Injectable Drug Delivery Market Outlook, By Curative Care(2016-2026) ($MN)
Table 23 Global Injectable Drug Delivery Market Outlook, By Other Usage Patterns (2016-2026) ($MN)
Table 24 Global Injectable Drug Delivery Market Outlook, By Facility of Use (2016-2026) ($MN)
Table 25 Global Injectable Drug Delivery Market Outlook, By Home Care Settings (2016-2026) ($MN)
Table 26 Global Injectable Drug Delivery Market Outlook, By Hospitals and Clinics(2016-2026) ($MN)
Table 27 Global Injectable Drug Delivery Market Outlook, By Other Facilities of Use (2016-2026) ($MN)
Table 28 Global Injectable Drug Delivery Market Outlook, By Site of Administration (2016-2026) ($MN)
Table 29 Global Injectable Drug Delivery Market Outlook, By Circulatory/Musculoskeletal System (Intravenous, Intracardiac, Intramuscular, and Intraperitoneal)(2016-2026) ($MN)
Table 30 Global Injectable Drug Delivery Market Outlook, By Skin (Intradermal and Subcutaneous)(2016-2026) ($MN)
Table 31 Global Injectable Drug Delivery Market Outlook, By Central Nervous System (Intracerebral and Intrathecal) (2016-2026) ($MN)
Table 32 Global Injectable Drug Delivery Market Outlook, By Organs (Intravitreal and Intra-Articular)(2016-2026) ($MN)
Table 33 Global Injectable Drug Delivery Market Outlook, By Application (2016-2026) ($MN)
Table 34 Global Injectable Drug Delivery Market Outlook, By Hormonal Disorders(2016-2026) ($MN)
Table 35 Global Injectable Drug Delivery Market Outlook, By Anemia (2016-2026) ($MN)
Table 36 Global Injectable Drug Delivery Market Outlook, By Antithrombotic/Thrombolytic Therapy (2016-2026) ($MN)
Table 37 Global Injectable Drug Delivery Market Outlook, By Growth Hormone Deficiency (GHD) (2016-2026) ($MN)
Table 38 Global Injectable Drug Delivery Market Outlook, By Diabetes (2016-2026) ($MN)
Table 39 Global Injectable Drug Delivery Market Outlook, By Osteoporosis (2016-2026) ($MN)
Table 40 Global Injectable Drug Delivery Market Outlook, By Reproductive Health Disease (2016-2026) ($MN)
Table 41 Global Injectable Drug Delivery Market Outlook, By Autoimmune Diseases (2016-2026) ($MN)
Table 42 Global Injectable Drug Delivery Market Outlook, By Multiple Sclerosis (MS) (2016-2026) ($MN)
Table 43 Global Injectable Drug Delivery Market Outlook, By Psoriasis (2016-2026) ($MN)
Table 44 Global Injectable Drug Delivery Market Outlook, By Rheumatoid Arthritis (2016-2026) ($MN)
Table 45 Global Injectable Drug Delivery Market Outlook, By Crohn’s Disease (2016-2026) ($MN)
Table 46 Global Injectable Drug Delivery Market Outlook, By Other Autoimmune Diseases (2016-2026) ($MN)
Table 47 Global Injectable Drug Delivery Market Outlook, By Cancer(2016-2026) ($MN)
Table 48 Global Injectable Drug Delivery Market Outlook, By Orphan Diseases(2016-2026) ($MN)
Table 49 Global Injectable Drug Delivery Market Outlook, By Cardiovascular diseases (2016-2026) ($MN)
Table 50 Global Injectable Drug Delivery Market Outlook, By Neurology Addiction (2016-2026) ($MN)
Table 51 Global Injectable Drug Delivery Market Outlook, By Respiratory Diseases (2016-2026) ($MN)
Table 52 Global Injectable Drug Delivery Market Outlook, By Regenerative Medicine (2016-2026) ($MN)
Table 53 Global Injectable Drug Delivery Market Outlook, By Oncology (2016-2026) ($MN)
Table 54 Global Injectable Drug Delivery Market Outlook, By Other Therapeutic Applications(2016-2026) ($MN)
Table 55 Global Injectable Drug Delivery Market Outlook, By Aesthetic Treatment (2016-2026) ($MN)
Table 56 Global Injectable Drug Delivery Market Outlook, By Pain Management (2016-2026) ($MN)
Table 57 Global Injectable Drug Delivery Market Outlook, By Hemophilia (2016-2026) ($MN)
Table 58 Global Injectable Drug Delivery Market Outlook, By Hepatitis C (2016-2026) ($MN)
Table 59 Global Injectable Drug Delivery Market Outlook, By Allergies (2016-2026) ($MN)
Table 60 Global Injectable Drug Delivery Market Outlook, By Distribution Channel (2016-2026) ($MN)
Table 61 Global Injectable Drug Delivery Market Outlook, By Retail Pharmacy Stores (2016-2026) ($MN)
Table 62 Global Injectable Drug Delivery Market Outlook, By Hospitals (2016-2026) ($MN)
Table 63 Global Injectable Drug Delivery Market Outlook, By E-Commerce (2016-2026) ($MN)
Table 64 Global Injectable Drug Delivery Market Outlook, By End User (2016-2026) ($MN)
Table 65 Global Injectable Drug Delivery Market Outlook, By Ambulatory Care (2016-2026) ($MN)
Table 66 Global Injectable Drug Delivery Market Outlook, By Home Based (2016-2026) ($MN)
Table 67 Global Injectable Drug Delivery Market Outlook, By Clinics/Physician Offices (2016-2026) ($MN)
Table 68 Global Injectable Drug Delivery Market Outlook, By Other End Users (2016-2026) ($MN)
Note: Regional tables for North America, Europe, Asia Pacific, South America and Middle East & Africa are presented in similar manner as the above.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report